Long-term Follow-up and Quality of Life of Patients Treated With Anticancer Drugs
Non-interventional and Longitudinal Study to Evaluate a List of Anticancer Drugs Under Real Conditions of Use and Measure the Quality of Life of Patients Treated at Rafaël Institute
Institut Rafael
300 participants
Mar 8, 2024
OBSERVATIONAL
Conditions
Summary
Currently, aspects related to the effects of anticancer treatments and the quality of life of patients and their needs are still poorly documented at the Rafael Institute. Thus this study will meet a dual objective: (1) the establishment of a registry to collect data on the safety and effectiveness of innovative and expensive anticancer drugs when administered in real life and (2) a measurement quantitative quality of life of patients treated with these drugs.
Eligibility
Inclusion Criteria4
- Age equal to or greater than 18 years (adult)
- Patients treated with an anticancer drug included in the list of innovative/expensive therapies (protocol appendix)
- Patients benefiting from non-pharmacological treatment at the Rafael Institute
- Who understands the French language
Exclusion Criteria2
- < 18 years old
- Patient deprived of liberty, under guardianship or unable to give consent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
o Quality of life questionnaires EORTC QLQC-30 and EQ-5D-5L ° questionnaires NCI- PRO-CTCAE
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06317714